DexCom
DXCM
DXCM
901 hedge funds and large institutions have $34.4B invested in DexCom in 2023 Q3 according to their latest regulatory filings, with 112 funds opening new positions, 347 increasing their positions, 332 reducing their positions, and 153 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less call options, than puts
Call options by funds: $503M | Put options by funds: $582M
27% less first-time investments, than exits
New positions opened: 112 | Existing positions closed: 153
27% less capital invested
Capital invested by funds: $47.3B → $34.4B (-$13B)
Holders
901
Holding in Top 10
17
Calls
$503M
Puts
$582M
Top Buyers
| 1 | +$393M | |
| 2 | +$209M | |
| 3 | +$164M | |
| 4 |
Holocene Advisors
New York
|
+$111M |
| 5 |
Neuberger Berman Group
New York
|
+$105M |
Top Sellers
| 1 | -$819M | |
| 2 | -$337M | |
| 3 | -$301M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$176M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$101M |